More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

The recent hurricanes in the US, including Puerto Rico, have underscored the role of climate and weather-related issues in supply chains. What is the impact on climate-related issues on the supply chain, and what do companies need to consider...

Digital health is touted as a key tool for patient compliance and knowledge, so what is the state of digital health in the pharmaceutical industry? Health-related mobile applications available to consumers now surpass 318,500, nearly double the...

As the UK seeks to exit the European Union (EU), the pharmaceutical industry has raised concerns over the impact of Brexit. A recent study by the European Federation of Pharmaceutical Industries and Associations (EFPIA), an industry trade...

The European Commission has issued a public consultation to gain feedback on a proposal to allow for a waiver for supplementary protection certificates (SPCs) and other changes in an effort to bolster the competitiveness of European manufacturing...

With the rise of increasingly complex active pharmaceutical ingredients (APIs), specifically biologics and poorly soluble small molecules, the number of parenteral drugs increases as well. Over the past three years, the percentage of parenteral new...

Financing into the biotechnology industry is an important measure for emerging pharmaceutical companies. So how are the dollars flowing thus far in 2017? In tracking US venture-capital funding, $2.2 billion was invested into biotechnology-related...

Orphan drugs accounted for only 7.9% of total drug sales in the U.S. in 2016, according to a recent QuintilesIMS study, but have accounted for more than 40% of new molecular entity approvals over the past three years. The FDA has recently moved to...

Pfizer announced earlier this month that it is considering strategic alternatives to its consumer healthcare business. So what options may be ahead? The over-the-counter (OTC) drug market has seen several high-profile moves over the past several...